Study of S 95005 in Combination With Oxaliplatin in Metastatic Colorectal Cancer

NCT02848443 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

78

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Colorectal Cancer

Interventions

DRUG: Trifluridine/tipiracil hydrochloride (S 95005)
DRUG: Oxaliplatin
DRUG: Bevacizumab
DRUG: Nivolumab

Sponsor

Institut de Recherches Internationales Servier

Collaborators

[object Object]